Thus, Dyrk1A might be an ideal therapeutic target for Alzheimer’s disease, especially for Down syndrome and EGCG which inhibits Dyrk1A may have potential effect on the treatment or prevention of this disease. The gene discussed is DYRK1A; the disease is early-onset autosomal dominant Alzheimer disease.